SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-157465
Filing Date
2020-06-02
Accepted
2020-06-01 17:39:16
Documents
14
Period of Report
2020-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d904458d8k.htm   iXBRL 8-K 42392
2 EX-2.1 d904458dex21.htm EX-2.1 22758
3 EX-2.2 d904458dex22.htm EX-2.2 35326
  Complete submission text file 0001193125-20-157465.txt   230866

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ck0001792044-20200529.xsd EX-101.SCH 2743
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001792044-20200529_lab.xml EX-101.LAB 15300
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001792044-20200529_pre.xml EX-101.PRE 9643
16 EXTRACTED XBRL INSTANCE DOCUMENT d904458d8k_htm.xml XML 3139
Mailing Address 235 EAST 42ND STREET NEW YORK NY 10017
Business Address 235 EAST 42ND STREET NEW YORK NY 10017 (212) 733-2323
Upjohn Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56114 | Film No.: 20934953
SIC: 2834 Pharmaceutical Preparations